Brief: Ix Biopharma Reports Positive Results From Wafermine Clinical Trial
05/09/2018 11:14
Sept 5 (Reuters) - IX Biopharma Ltd IXBI.SI :
* REPORTS POSITIVE RESULTS FROM WAFERMINE PHASE 2 MULTI-DOSE
CLINICAL EFFICACY TRIAL
Source text (https://bit.ly/2NmT00K)
Further company coverage: IXBI.SI
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IX Biopharma
See all newsBrief: Ix Biopharma Confirms Orion Not Yet Obtained Licence From Nevada State Board Of Pharmacy
Brief: Ix Biopharma Says U.S. Govt Opens Emergency Pathway, Clears Path For Wafermine Application For EUA
Brief: IX Biopharma Says Co Will Undertake An Internal Restructuring Of Its Consumer Business
Brief: IX Biopharma To Issue 1 MLN New Shares To Anson Properties At S$0.4215 Per Share
Brief: IX Biopharma Says US Government Awards US$41 MLN Contract To Fund Development Of Wafermine